The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
|Articles|March 2, 2014
Visit Our Booth
Visit Our Booth
Advertisement
Since 1993, GlobePharma has been Innovating the Industry Standard with Powder, Liquid &Semi-Solid Samplers, Cleaning Validation Tools, Powder Segregation Tester, MaxiBlend® R&D & Pilot Scale Blenders, SimpleBlend™, Patented Sift-N-Blend™, cGMP Valves, Manual Compaction Machine, Tablet Presses, Granulators, Deduster, Polisher, Cone Mill.
GlobePharma, New Brunswick, NJ
•
INTERPHEX Booth # 2554
Advertisement
Related to this article
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Can AI Agents Satisfy CGMP Documentation Requirements?
2
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
3
Introducing the "PharmTech AI Pulse Check" Expert Video Series
4
Two Audit Case Studies Reveal the Cost of Incomplete Corrective Actions
5